CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 405 enrolled
Drug / intervention
Change in knowledge, motivation, skills, resourcesbehavioral
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04542343
NCT04542343N/ACompleted

Multilevel, Multidisciplinary, Faith-Based Participatory Interventions to Reduce COVID-19 Related-Risks Among Underserved African Americans

Charles Drew University of Medicine and Science·interventional·Posted Sep 9, 2020·Updated May 22, 2024

In Brief

A clinical study evaluating Change in knowledge, motivation, skills, resources for Coronavirus. Completed, enrolled 405 participants across 1 site.

Detailed Summary

African American adults, specifically those managing chronic disease and social isolation, are one of the most vulnerable groups susceptible to COVID-19. This intervention involves a multi-disciplinary and culturally sensitive approach to address two major COVID-19 related challenges in this population. First, this program collaborates with predominantly African American churches to implement Federal and State guidelines aimed at preventing outbreaks of COVID-19 at faith-based gatherings. Second, this program trains church-based health advisors to help African American older parishioners manage their chronic health conditions and reduce psychological distress during the pandemic.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsCoronavirus
CountriesUnited States

Timeline

N/ACompletedFinished
202120222023202420252026
First PostedSep 9, 2020
Enrollment StartJun 1, 2021
Primary CompletionDec 30, 2022
TodayJul 2, 2026
Enrollment to primary: 1.6 yearsPosted 5.8 years ago

Interventions

Change in knowledge, motivation, skills, resourcesbehavioral

Provide/enhance knowledge, modify attitudes, motivate and provide skills and resources to reduce COVID-19 related risk and challenges.